Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

DC1 native/mutated ESR1

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · PHASE 1 TRIAL

Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer

ClinicalTrials.gov

Phase 1 pilot study of a novel dendritic cell vaccine combined with elacestrant in metastatic breast cancer; designed to assess feasibility and safety, not efficacy, with no results yet reported in this registry record.

PreliminaryHER2 Negative Breast Cancer NCT06691035 DC1 native/mutated ESR1

Reported

Planned enrollment18

PhasePhase 1

Primary outcome measure 1Rate of Successful Completion, up to 2 years

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support